Table 2:
Response and outcomes to avelumab maintenance treatment
| (N=108) | |
|---|---|
| Best response to Avelumab maintenance | |
| Complete Response | 19 (17.6) |
| Partial Response | 12 (11.1) |
| Stable Disease | 32 (29.6) |
| Progressive Disease | 29 (26.9) |
| Unknown* | 16 (14.8) |
| Overall Response Rate (ORR) % | 28.7% |
| Reason of avelumab discontinuation | |
| Clinical Progression | 12 (11.1) |
| Radiographic Progression | 34 (31.5) |
| Toxicity | 6 (5.6) |
| Other | 8 (7.4) |
| Patient still on treatment | 48 (44.4) |
*
Most of those patients did not have response evaluation or were lost to follow-up